Alternative to Lenalidomide ID ' d for Maintenance in Multiple Myeloma
WEDNESDAY, Feb. 1, 2023 -- For patients with newly diagnosed multiple myeloma after induction treatment and autologous stem cell transplantation, maintenance therapy with carfilzomib, lenalidomide, and dexamethasone may be better than lenalidomide...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Dexamethasone | Myeloma | Pharmaceuticals | Revlimid | Stem Cell Therapy | Stem Cells | Transplants